Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: A preliminary analysis-Reference-Cited by-同舟云学术

Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: A preliminary analysis

Published:2005-09 Issue:3 Volume:66 Page:547-551
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Zhu Hui,Roehl Kimberly A.,Antenor Jo Ann V.,Catalona William J.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements;Catalona;JAMA,1997

3. The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy;Babaian;J Urol,2001

4. Analysis of 233,989 prostate biopsies from 1997 to 2002 confirms the trend of decreasing age of patients undergoing biopsy but does not demonstrate any alteration in the overall detection rate of prostate cancer;Lowe;J Urol,2003

5. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer;Schroder;J Natl Cancer Inst,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml;Frontiers in Oncology;2022-07-28

2. Prostate Cancer Screening;Medical Clinics of North America;2018-03

3. Prostate Cancer Screening in a New Era of Genetics;Clinical Genitourinary Cancer;2017-12

4. Full-length antibodies versus single-chain antibody fragments for a selective impedimetric lectin-based glycoprofiling of prostate specific antigen;Electrochimica Acta;2017-08

5. Our Prostate Biopsy Results in The Patients with Prostate Specific Antigen Levels Below 4 ng/ml;Annals of Clinical and Analytical Medicine;2015